BioSpace News Archive

Business

Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2020 Release Date

Kewaunee Scientific Corporation announced that the Company plans to release its third quarter fiscal year 2020 financial results on Tuesday, March 3, 2020 after the close of trading.

February 18, 2020

·

2 min read

Biotech Beach

Huntington Hospital Earns Blue Distinction® Center Designation for Quality in Knee and Hip Replacement Surgeries

Blue Shield of California has selected Huntington Hospital as a Blue Distinction Center for Knee and Hip Replacement, part of the Blue Distinction Specialty Care program.

February 18, 2020

·

5 min read

Biotech Beach

Viracta’s Precision Oncology Research in EBV+ Cancers Highlighted at 16th Annual UCSD Moores Cancer Center Symposium

Viracta Therapeutics, Inc. announced that Ivor Royston, M.D., the Company’s President and CEO, will present an overview of Viracta’s approach in treating patients with Epstein-Barr Virus -associated malignancies and data from the ongoing Phase 2 clinical trial in lymphoma.

February 18, 2020

·

3 min read

Pharm Country

Avantor® to Participate in Cowen and Company’s 40th Annual Health Care Conference

Avantor, Inc. announced that Michael Stubblefield, President and Chief Executive Officer, will participate in Cowen and Company’s 40th Annual Health Care Conference at the Boston Marriott Copley Place Hotel in Boston, Massachusetts.

February 18, 2020

·

1 min read

Genetown

Dicerna™ to Present at Upcoming Investor Conferences - Feb. 18, 2020

Dicerna Pharmaceuticals, Inc. announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present a corporate overview at two upcoming investor conferences

February 18, 2020

·

2 min read

Business

Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance

Amedisys, Inc. reported its financial results for the three month period and year ended December 31, 2019.

February 18, 2020

·

8 min read

Policy

US FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)

Retrotope announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for its chemically-modified polyunsaturated fatty acid drug for the treatment of Progressive SupraNuclear Palsy.

February 18, 2020

·

5 min read

Biotech Bay

Personalis, Inc. to Present at Biomarkers Series UK 2020 Conference

Personalis, Inc., a leader in advanced genomics for cancer, announced that the company will present at the Biomarkers Series UK 2020 conference in Manchester, UK, February 19-20.

February 18, 2020

·

2 min read

Business

bluebird bio Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Operational Progress

First conditional approval of ZYNTEGLOTM (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years and older with transfusion-dependent β-thalassemia who do not have β0/β0 genotype in Europe achieved in 2019; Germany launch underway

February 18, 2020

·

16 min read

Business

Affinity Dental Management Expands Footprint Into Metro New York

Affinity Dental Management, Inc., a dental services organization that provides comprehensive management and administrative support services for dental practices, has added the powerhouse dental practice, Concerned Dental to its growing platform.

February 18, 2020

·

3 min read